Indication
Recurrent pericarditis
Recurrent pericarditis is an autoinflammatory cardiovascular condition characterized by repeated flares of inflammation affecting the fibroelastic sac surrounding the heart, occurring after a documented symptom-free interval of at least 4 to 6 weeks following an initial or prior acute episode. Read more about Recurrent pericarditis
2 drugs 2 manufacturers
Drugs that treat it
Common Recurrent pericarditis therapies.
ARCALYST (rilonacept)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRecurrent pericarditis is an autoinflammatory cardiovascular condition characterized by repeated flares of inflammation affecting the fibroelastic sac surrounding the heart, occurring after a documented symptom-free interval of at least 4 to 6 weeks following an initial or prior acute episode.
It develops as a complication in approximately 15% to 30% of patients following acute pericarditis and is predominantly driven by innate immune dysregulation, often involving the interleukin-1 signaling cascade.
Defining clinical features include positional, pleuritic chest pain alongside objective evidence of disease activity, such as elevated systemic inflammatory biomarkers, a pericardial friction rub, diagnostic electrocardiographic changes, new or worsening pericardial effusion, and late gadolinium enhancement on cardiac magnetic resonance imaging.
- heart.org
Recurrent pericarditis is an autoinflammatory cardiovascular condition characterized by repeated flares of inflammation affecting the fibroelastic sac surrounding the heart, occurring after a documented symptom-free interval of at least 4 to 6 weeks following an initial or prior acute episode
- nih.gov
Recurrent pericarditis is an autoinflammatory cardiovascular condition characterized by repeated flares of inflammation affecting the fibroelastic sac surrounding the heart, occurring after a documented symptom-free interval of at least 4 to 6 weeks following an initial or prior acute episode It develops as a complication in approximately 15% to 30% of patients following acute pericarditis and is predominantly driven by innate immune dysregulation, often involving the interleukin-1 signaling cas...
- rarediseases.org
Recurrent pericarditis is an autoinflammatory cardiovascular condition characterized by repeated flares of inflammation affecting the fibroelastic sac surrounding the heart, occurring after a documented symptom-free interval of at least 4 to 6 weeks following an initial or prior acute episode
- nih.gov
It develops as a complication in approximately 15% to 30% of patients following acute pericarditis and is predominantly driven by innate immune dysregulation, often involving the interleukin-1 signaling cascade
- nih.gov
Defining clinical features include positional, pleuritic chest pain alongside objective evidence of disease activity, such as elevated systemic inflammatory biomarkers, a pericardial friction rub, diagnostic electrocardiographic changes, new or worsening pericardial effusion, and late gadolinium enhancement on cardiac magnetic resonance imaging
- acc.org
Defining clinical features include positional, pleuritic chest pain alongside objective evidence of disease activity, such as elevated systemic inflammatory biomarkers, a pericardial friction rub, diagnostic electrocardiographic changes, new or worsening pericardial effusion, and late gadolinium enhancement on cardiac magnetic resonance imaging
- acc.org
Defining clinical features include positional, pleuritic chest pain alongside objective evidence of disease activity, such as elevated systemic inflammatory biomarkers, a pericardial friction rub, diagnostic electrocardiographic changes, new or worsening pericardial effusion, and late gadolinium enhancement on cardiac magnetic resonance imaging
Personalize your experience
Follow Recurrent pericarditis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.